Kelly Financial Services LLC Biomarin Pharmaceutical Inc Transaction History

Kelly Financial Services LLC

  • $258 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jul 17, 2024
SELL
$71.72 - $91.47 $1,434 - $1,829
-20 Closed
0 $0
Q3 2021

Jul 17, 2024
SELL
$74.77 - $85.47 $123,295 - $140,940
-1,649 Reduced 98.8%
20 $1.55 Million
Q2 2021

Jul 17, 2024
BUY
$75.51 - $84.79 $119,683 - $134,392
1,585 Added 1886.9%
1,669 $20,000
Q1 2021

Jul 17, 2024
BUY
$74.73 - $90.69 $6,277 - $7,617
84 New
84 $6.34 Million

Others Institutions Holding BMRN

# of Institutions
618
Shares Held
181M
Call Options Held
1.4M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email